CancerDual PARP1-IKZF3 degrader overcomes PARP inhibitor resistanceResearchers from the Ocean University of China described XZ-8078, a new dual-target protein degrader that simultaneously targets PARP1 and IKZF3, offering a potential strategy to enhance antitumor activity through coordinated pathway inhibition.